HBSGX | WCMNX | HBSGX / WCMNX | |
Total Expense Ratio | 0.90 | 1.24 | 73% |
Annual Report Gross Expense Ratio | 0.90 | 2.04 | 44% |
Fund Existence | 23 years | 6 years | - |
Gain YTD | -14.868 | 9.062 | -164% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 547M | 43M | 1,272% |
Annual Yield % from dividends | 2.76 | 0.00 | - |
Returns for 1 year | -17.19 | 3.52 | -489% |
Returns for 3 years | 14.96 | 38.82 | 39% |
Returns for 5 years | -21.72 | 16.11 | -135% |
Returns for 10 years | -5.62 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 31.41 | 1.31 | +4.34% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
JPSE | 50.47 | 0.78 | +1.57% |
JPMorgan Divers Ret US Small Cap Eq ETF | |||
SPYH | 55.05 | 0.41 | +0.76% |
NEOS S&P 500 Hedged Equity Income ETF | |||
PAI | 12.65 | -0.03 | -0.24% |
Western Asset Investment Grade Income Fund | |||
BSCR | 19.72 | -0.06 | -0.30% |
Invesco BulletShares 2027 Corp Bd ETF |